Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
World J Gastroenterol ; 10(18): 2723-6, 2004 Sep 15.
Artigo em Inglês | MEDLINE | ID: mdl-15309727

RESUMO

AIM: To examine the effects of ovarian hormone on the expression of 5-hydroxytryptamine 3 receptors (5-HT3R) in rat colon of restraint stress-induced bowel dysfunction. METHODS: Twenty-four female Sprague-Dawley rats were randomly divided into three groups of 8 each: sham operation, ovariectomy (OVX) and ovariectomy with estrogen (E2) and progesterone (P) replacement therapy (OVX+E2+P). The rats were subjected to 1-h restraint stress 4 wk after operation. The changes of defecation were monitored by collection of fecal pellets. The gonadal steroids were measured in duplicate by radioimmunoassay (RIA). The expression of 5-HT3R mRNA in the colon was studied by RT-PCR. RESULTS: Compared with sham group and OVX+E2+P group, OVX group showed increase in fecal pellets and decrease in the time of vitreous pellets excretion (P<0.01). Serum levels of E2 and P were suppressed in OVX group and restored following treatment with ovarian steroids (P<0.01), and the levels of 5-HT3R mRNA in the colon of ovariectomized rats were significantly increased, the expression of 5-HT3R mRNA was significantly decreased in hormone replacement therapy group (P<0.01). CONCLUSION: Ovarian hormone plays a role in the regulation of 5-HT3R expressions in restraint stress-induced bowel dysfunction of rats. The interactions between ovarian steroids and gastrointestinal tract may have major pathophysiological implications in 5-HT-related disorders, such as irritable bowel syndrome (IBS).


Assuntos
Estradiol/farmacologia , Síndrome do Intestino Irritável/fisiopatologia , Progesterona/farmacologia , Receptores 5-HT3 de Serotonina/genética , Estresse Fisiológico/fisiopatologia , Animais , Colo/fisiopatologia , Defecação , Feminino , Expressão Gênica/efeitos dos fármacos , Síndrome do Intestino Irritável/etiologia , Ovariectomia , RNA Mensageiro/metabolismo , Ratos , Ratos Sprague-Dawley , Restrição Física , Estresse Fisiológico/complicações
2.
World J Gastroenterol ; 9(7): 1427-30, 2003 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-12854134

RESUMO

AIM: To study the preventive effect of hydrotalcite on gastric mucosal injury in rat induced by taurocholate, and to investigate the relationship between the protective mechanism of hydrotalcite and the expression of trefoil factor family 2 (TFF2) mRNA and c-fos protein. METHODS: Forty five male Wistar rats were randomly divided into hydrotalcite group, ranitidine group and control group. Gastric mucosal injury was induced by introgastric acidified taurocholate. OD value of TFF2 mRNA expression in gastric mucous cells was determined by hybridization and computer image analysis system. OD value of c-fos protein expression in gastric mucous cells was measured by immunohistochemistry and computer image analysis system. RESULTS: The gross mucosal injury index in hydrotalcite group was significantly lower than that in ranitidine group and control group (8.60+/-2.20 vs 16.32+/-4.27, 29.53+/-5.39; P<0.05, P<0.01). The expression level of TFF2 mRNA in hydrotalcite group was markedly higher than that in ranitidine group and control group (0.56+/-0.09 vs 0.30+/-0.05, 0.28+/-0.03, P<0.05). The OD value of c-fos protein in hydrotalcite group was higher than that in ranitidine group and control group (0.52+/-0.07 vs 0.31+/-0.04, 0.32+/-0.05, P<0.05). CONCLUSION: Hydrotalcite can protect gastric mucosal injury in rats induced by taurocholate, which may be related to the increased expression of TFF2 and c-fos protein.


Assuntos
Hidróxido de Alumínio/farmacologia , Antiácidos/farmacologia , Hidróxido de Magnésio/farmacologia , Mucinas , Proteínas Musculares , Neuropeptídeos , Gastropatias/prevenção & controle , Animais , Colagogos e Coleréticos , Edema/induzido quimicamente , Edema/patologia , Edema/prevenção & controle , Mucosa Gástrica/efeitos dos fármacos , Mucosa Gástrica/patologia , Hiperemia/induzido quimicamente , Hiperemia/patologia , Hiperemia/prevenção & controle , Masculino , Peptídeos/genética , Proteínas Proto-Oncogênicas c-fos/genética , RNA Mensageiro/análise , Ratos , Ratos Wistar , Gastropatias/induzido quimicamente , Gastropatias/patologia , Ácido Taurocólico , Fator Trefoil-2 , Fator Trefoil-3
3.
World J Gastroenterol ; 9(5): 910-4, 2003 May.
Artigo em Inglês | MEDLINE | ID: mdl-12717829

RESUMO

AIM: To investigate the expression of TFF2 and Helicobacter pylori infection in carcinogenesis of gastric mucosa. METHODS: The expression of TFF2 was immunohistochemically analyzed in paraffin-embedded samples from 119 patients with endoscopic biopsy and subtotal gastrectomy specimens of gastric mucosal lesions, including 16 cases of chronic superficial gastritis (CSG), 20 chronic atrophic gastritis (CAG), 35 intestinal metaplasia (IM), 23 gastric epithelial dysplasia (GED) and 25 gastric carcinoma (CA), and Helicobacter pylori infection was detected by Warthin-Starry staining. RESULTS: 1: TFF2 was located in the cytoplasm of gastric mucous neck cell. The expression of TFF2 was 100 %, 100 %, 0, 56.5 % and 0 in CSGs, CAGs, IMs, GEDs and CAs, respectively. 2: The value of TFF2 positive cell density in CSG with Helicobacter pylori infection was higher than that without Helicobacter pylori infection. (52.89+/-7.27 vs 46.49+/-13.04, P>0.05); But the value of TFF2 positive cell density in CAG and GED with Helicobacter pylori infection was significantly lower than that without Helicobacter pylori infection (18.17+/-4.09 vs 37.93+/-13.80, P<0.01 and 14.44+/-9.32 vs 24.84+/-10.22, P<0.05). CONCLUSION: Increase of TFF2 expression in CSG is perhaps associated with the protective mechanism after gastric mucosal injury. Decrease of TFF2 expression in CAG possibly attributes to the decrease in the number of gastric gland cell expressing TFF2. Re-expression of TFF2 in gastric epithelial dysplasia implies that TFF2 possibly contributes to the initiation of gastric carcinoma. The effect of Helicobacter pylori on the expression of TFF2 depends on the status of gastric mucosa.


Assuntos
Substâncias de Crescimento/metabolismo , Infecções por Helicobacter/complicações , Helicobacter pylori , Mucinas , Proteínas Musculares , Neuropeptídeos , Peptídeos/metabolismo , Neoplasias Gástricas/complicações , Neoplasias Gástricas/metabolismo , Doença Crônica , Mucosa Gástrica/metabolismo , Mucosa Gástrica/patologia , Gastrite/complicações , Gastrite/metabolismo , Gastrite/patologia , Gastrite Atrófica/complicações , Gastrite Atrófica/metabolismo , Gastrite Atrófica/patologia , Infecções por Helicobacter/patologia , Humanos , Imuno-Histoquímica , Metaplasia , Neoplasias Gástricas/etiologia , Neoplasias Gástricas/patologia , Fator Trefoil-2 , Fator Trefoil-3
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA